Cancer diagnosis and treatment redefine normality, with chronic conditions like follicular lymphoma posing ongoing challenges ...

Everyday, more than 500 Central New Yorks will come to the Upstate Cancer Center or another location to get chemo, radiation ...

A study published in Cancer Discovery finds that combining an epigenetic therapy with an anti-PD-1 antibody, which uses the ...

Every year, more than 80,000 Americans hear these life-changing words: You have non-Hodgkin’s lymphoma, a blood cancer.

Tattoos may increase the risk of developing lymphoma and skin cancer, a recent study suggests. "We can see that ink particles accumulate in the lymph nodes, and we suspect that the body perceives them ...

A Swedish study has found a potential link between tattoos and a type of cancer called malignant lymphoma, but it ultimately calls for more research on the topic, and cancer experts say the possible ...

Scientists have warned of an urgent need for more research into the long-term health impacts of tattoos after new research found they may increase the risk of lymphoma cancer. Roughly one third of ...

Combining an epigenetic therapy with an anti-PD-1 antibody, which uses the body's natural response to viral infections, ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Stage 2 Hodgkin’s lymphoma is an early stage of this cancer. Healthcare professionals describe Hodgkin’s lymphoma as stage 2 when a person has cancer in two or more lymph node groups, either below or ...

Getting a tattoo, regardless of its size, increases the risk of developing lymphoma by 21%, according to a new study. The researchers say they’re not trying to dissuade people from getting inked, they ...

How Does Columvi Work for DLBCL and LBCL? Columvi is a special type of molecule that can attach to two different types of cells. This is called a bispecific antibody. It attaches to CD20 proteins on ...